Coursera, Inc. (BMV:COUR)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	35,738	28,055	49,954	33,824	69,063	-
Market Cap Growth	30.58%	-43.84%	47.69%	-51.02%	-	-
Enterprise Value	21,361	13,142	37,906	18,799	52,772	-
Last Close Price	220.00	332.00	337.00	479.00	479.00	-
PS Ratio	2.63	1.94	4.65	3.31	8.11	-
PB Ratio	3.02	2.25	4.80	2.50	4.54	-
P/TBV Ratio	3.16	2.35	4.89	2.53	4.61	-
P/FCF Ratio	16.64	14.36	103.71	-	17546.11	-
P/OCF Ratio	16.33	14.12	99.70	-	1929.47	-
EV/Sales Ratio	1.60	0.91	3.53	1.84	6.20	-
EV/FCF Ratio	9.95	6.73	78.69	-	13407.19	-
Debt / Equity Ratio	-	0.01	0.01	0.02	0.03	0.11
Debt / FCF Ratio	-	0.03	0.23	-	103.62	-
Asset Turnover	0.77	0.75	0.68	0.55	0.60	0.90
Quick Ratio	2.43	2.40	2.65	3.44	4.26	2.12
Current Ratio	2.55	2.54	2.79	3.61	4.44	2.31
Return on Equity (ROE)	-8.40%	-13.11%	-17.78%	-24.42%	-29.58%	-34.61%
Return on Assets (ROA)	-4.88%	-6.89%	-9.93%	-10.56%	-12.99%	-12.73%
Return on Capital (ROIC)	-7.57%	-10.43%	-13.92%	-13.69%	-17.39%	-20.18%
Earnings Yield	-2.69%	-5.91%	-3.94%	-10.11%	-4.31%	-
FCF Yield	6.01%	6.97%	0.96%	-2.28%	0.01%	-
Buyback Yield / Dilution	-3.71%	-4.25%	-3.92%	-27.89%	-205.28%	-15.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.